118 related articles for article (PubMed ID: 38413367)
1. Design, Synthesis, and Biological Evaluation of
Lin G; Xu Q; Li J; Chu Z; Ma X; Zhu Q; Zhao Y; Mo J; Ye W; Shao L; Fang T; He M; Yue S; Dai M
J Med Chem; 2024 Mar; 67(5):3358-3384. PubMed ID: 38413367
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.
Xu Q; Hu M; Li J; Ma X; Chu Z; Zhu Q; Zhang Y; Zhu P; Huang Y; He G
Eur J Med Chem; 2022 Jan; 227():113876. PubMed ID: 34710748
[TBL] [Abstract][Full Text] [Related]
3. An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.
El Fadili M; Er-Rajy M; Ali Eltayb W; Kara M; Imtara H; Zarougui S; Al-Hoshani N; Hamadi A; Elhallaoui M
J Biomol Struct Dyn; 2024 Aug; 42(12):6174-6188. PubMed ID: 37428078
[TBL] [Abstract][Full Text] [Related]
4. Characterization of (
Ahmed H; Wallimann R; Gisler L; Elghazawy NH; Gruber S; Keller C; Liang SH; Sippl W; Haider A; Ametamey SM
ACS Chem Neurosci; 2023 Dec; 14(24):4323-4334. PubMed ID: 38060344
[TBL] [Abstract][Full Text] [Related]
5. The discovery of subunit-selective GluN1/GluN2B NMDAR antagonist via pharmacophere-based virtual screening.
Tang J; Jin J; Huang Z; An F; Huang C; Jiang W
Exp Biol Med (Maywood); 2023 Dec; 248(24):2560-2577. PubMed ID: 38282535
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel tryptamine derivatives as GluN2B subunit-containing NMDA receptor antagonists via pharmacophore-merging strategy with orally available therapeutic effect of cerebral ischemia.
Quan J; Yang H; Qin F; He Y; Liu J; Zhao Y; Ma C; Cheng M
Eur J Med Chem; 2023 May; 253():115318. PubMed ID: 37037139
[TBL] [Abstract][Full Text] [Related]
7. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
[TBL] [Abstract][Full Text] [Related]
8. Agmatine preferentially antagonizes GluN2B-containing N-methyl-d-aspartate receptors in spinal cord.
Waataja JJ; Peterson CD; Verma H; Goracke-Postle CJ; Séguéla P; Delpire E; Wilcox GL; Fairbanks CA
J Neurophysiol; 2019 Feb; 121(2):662-671. PubMed ID: 30427758
[TBL] [Abstract][Full Text] [Related]
9. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
10. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
[TBL] [Abstract][Full Text] [Related]
11. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
[TBL] [Abstract][Full Text] [Related]
12. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
Chen X; Keramidas A; Harvey RJ; Lynch JW
Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
[TBL] [Abstract][Full Text] [Related]
13. Epileptiform GluN2B-driven excitation in hippocampus as a therapeutic target against temporal lobe epilepsy.
Gorlewicz A; Pijet B; Orlova K; Kaczmarek L; Knapska E
Exp Neurol; 2022 Aug; 354():114087. PubMed ID: 35469852
[TBL] [Abstract][Full Text] [Related]
14. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor.
Wee XK; Ng KS; Leung HW; Cheong YP; Kong KH; Ng FM; Soh W; Lam Y; Low CM
Br J Pharmacol; 2010 Jan; 159(2):449-61. PubMed ID: 20082612
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of Benzazepine-Based PET Radioligands (
Haider A; Herde AM; Krämer SD; Varisco J; Keller C; Frauenknecht K; Auberson YP; Temme L; Robaa D; Sippl W; Schibli R; Wünsch B; Mu L; Ametamey SM
J Nucl Med; 2019 Aug; 60(8):1167-1173. PubMed ID: 30683765
[TBL] [Abstract][Full Text] [Related]
16. Phenol-Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B-selective N-methyl- d-aspartate receptor antagonists.
Markus A; Schreiber JA; Goerges G; Frehland B; Seebohm G; Schepmann D; Wünsch B
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200147. PubMed ID: 35606894
[TBL] [Abstract][Full Text] [Related]
17. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
[TBL] [Abstract][Full Text] [Related]
18. Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.
Baumeister S; Schepmann D; Wünsch B
Bioorg Med Chem; 2020 Jan; 28(2):115245. PubMed ID: 31843460
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways.
Rittase WB; Dong Y; Barksdale D; Galdzicki Z; Bausch SB
Mol Cell Neurosci; 2014 May; 60():63-71. PubMed ID: 24769103
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
